| Financial Year |
March 31 2023 |
| Monetary Funds |
447,406,983.33 |
| Held-for-trading Financial Assets |
772,827.38 |
| Notes Receivable |
126,230,122.35 |
| Accounts Receivable |
1,079,745,730.94 |
| Advances to Suppliers |
160,348,292.14 |
| Other Receivables |
7,641,036.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
344,229,807.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,993,263.90 |
| Total Current Assets |
2,193,163,082.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,804,959.46 |
| Investment Properties |
137,928,328.13 |
| Fixed Assetes |
418,190,973.49 |
| Under-construction Projects |
193,045,382.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
147,419,708.49 |
| R&D expenses |
-- |
| Goodwill |
331,806,438.01 |
| Long-Term Deferred and Prepaid Expenses |
4,779,675.25 |
| Deferred Income Tax Assets |
15,341,051.40 |
| Other Non-Current Assets |
70,815,266.89 |
| Sub-Total of Non-Current Assets |
1,327,493,934.18 |
| Total Assets |
3,520,657,017.15 |
| Short-Term Loans |
820,153,870.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
240,138,405.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,144,449.70 |
| Taxes Payable |
36,786,874.95 |
| Interest Payable |
1,236,437.19 |
| Dividend Payable |
197,925.00 |
| Other payables |
435,458,025.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,076,187.11 |
| Other Current Liabilities |
13,525,162.11 |
| Sub-Total of Current Liabilities |
1,665,950,369.98 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,498,147.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,570,235.40 |
| Total Liabilities |
1,690,520,605.38 |
| Paid-In Capital(Or Share Stock) |
507,725,100.00 |
| Capital Surplus |
687,079,731.15 |
| Surplus Reserve |
31,368,185.86 |
| LESS:Treasury Stock |
17,162,923.39 |
| Undistributed Profits |
251,445,115.06 |
| Minority Stockholder's Interest |
368,668,410.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,461,468,001.76 |
| Owner's Equity（Stockholder's Equity） |
1,830,136,411.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,520,657,017.15 |
